Call Options Transactions Made in Q2 2025 in Rocket Pharmaceuticals, Inc. (RCKT)
This table provides information about the institutional ownership of Rocket Pharmaceuticals, Inc. (RCKT) during Q2 2025. The information is specifically focused on institutions that hold call options of ROCKET PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2025
Q2 2025
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
85.3K+ 44.92% |
$199K - $683K
|
275K
$801K
|
|
|
Aug 14, 2025
Q2 2025
|
Jane Street Group, LLC
New York, NY |
BUY
|
CALL |
56.4K+ 400.0% |
$131K - $452K
|
70.5K
$205K
|
|
|
Aug 14, 2025
Q2 2025
|
Nomura Holdings Inc
Tokyo, M0 |
BUY
|
CALL |
28.8KNew |
$67.1K - $231K
|
28.8K
$83.8K
|
|
|
Aug 14, 2025
Q2 2025
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
3.2K+ 5.81% |
$7.46K - $25.6K
|
58.3K
$170K
|
|
|
Jul 25, 2025
Q2 2025
|
Concurrent Investment Advisors, LLC
Tampa, FL |
BUY
|
CALL |
2.5KNew |
$5.83K - $20K
|
2.5K
$7.28K
|
|
|
Aug 13, 2025
Q2 2025
|
Myda Advisors LLC
Inwood, NY |
SELL
|
CALL |
-61K- 74.21% |
$142K - $489K
|
21.2K
$61.7K
|